Navigation Links
Smart Balance Announces 2008 First-Quarter Results
Date:5/7/2008

s $50,766 $40,583

COGS 27,938 20,672

Gross Profit 22,828 19,911

Gross margins 45.0% 49.1%

Marketing 7,225 6,901

Selling 5,057 3,450

G&A 8,584 1,403

Total SG&A 20,866 11,754

Operating Income 1,962 8,157

% of Net Sales 3.9% 20.1%

Operating Income includes the following

non-cash items

FAS 123R Stock Options 3,534 --

Depreciation 53 6

Amortization 1,022 --

4,609 6

Operating Income net of non-cash items: 6,571 8,163

% of Net Sales 12.9% 20.1%

(1) The Company's GAAP financial statements include the results of its

acquisition of GFA Brands, Inc. since the date of acquisition on

May 21, 2007. Because there were no operations prior to the

acquisition, prior periods are not comparable. The operating basis

results should not be viewed in isolation or as a substitute for

reported GAAP results. Please refer to the reconciliation of operating

basis results to GAAP results provided for in the accompanying table.

Smart Balance, Inc.

Reconciliation of Operating Basis to GAAP Basis

Prior to Smart Balance, Inc.'s May 21, 2007 acquisi
'/>"/>

SOURCE Smart Balance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Netsmart Technologies Introduces the Netsmart Connect(TM) Suite of Solutions for Behavioral and Public Healthcare
2. Smart Balance Inc. to Hold Annual Meeting of Stockholders on May 21, 2008
3. Dempsters Smart(TM) 100% Whole Grain Wheat Bread Launched With lifesDHA(TM)
4. Outsmart the Summer Sun at Any Age
5. Smart Balance Announces Sales Organization Appointments
6. PARADE Magazine Features Smart Genetics and Alzheimers Mirror
7. American Academy of Dermatology Issues Statement Urging the Public to be Sun Smart(SM)
8. Study: Pregnant Women Who Eat More Fish, Including Canned Tuna, Have Smarter Children
9. Smart Balance Presented at Citi Small/Midcap Conference
10. Smart Balance to Webcast Presentation at Citi Small/Midcap Conference
11. Smart Circle International, LLC Launches Its National Health and Wellness Network Complimentary 1/2-Hour Massage for Everyone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...m workers are three times as likely as all other c...hildren to be uninsured, according to a report in ...lescent Medicine, one of the JAMA/Archives journal...health challenges, according to background informa... already has suboptimal access to pediatric health...
(Date:12/2/2008)...asylol have a higher death risk, data review finds...- A new study casts more doubt on the safety of th...g in patients undergoing surgery. , Trasylol is...States, where it was removed from the market in 20... researchers reviewed findings from 49 randomized ...
(Date:12/2/2008)...or Tuesday, December 2, 2008 at 3 pm CST)--Radiolo... University of South Carolina in Charleston, S.C.,...cer from exposure to radiation during computed tom...ated and that new estimates are several times lowe... researchers presented their findings at the annu...
(Date:12/2/2008)...PRNewswire-FirstCall/ -- United American Healthcar...rovides comprehensive healthcare,management servi...oday,announced that its Board of Directors has ap...e Company to repurchase up to $1.0 million of its ...lows for the Company,s common shares to be purchas...
Breaking Medicine News(10 mins):Health News:1/3 of farm workers' children lack health insurance 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2
...nsurance plans show wide variations among differen...premium dollar. // -Employees in the smallest fir... insurance premiums than those in the largest firm...--the percentage of total medical expenses paid by...
...egulatory body is set up by the Indian information...ter the theft of data, by 3 employees of a BPO fir... in the IT industry. The move is to bolster overse... of instances have stirred the IT sector to set up...
...ptive pill, Dianette also used to treat acne, has ...rities after concerns were expressed about its lin...ntraceptive that was licensed as a hormone treatme...r review when over 100 women said they suffered de...
...n Ilhan tenderly kissed his 2-year-old daughter, J... as he kissed Jaida, he noticed that her face bega... whether it was caused by something she ate or som...t it was me,' he recalled. 'I ate some peanuts tha...
Other Medicine News:Health News:Health Insurance Plans Varies among States 2Health News:Health Insurance Plans Varies among States 3Health News:Allergic to Kisses? 2
(Date:12/2/2008)..., Kan., Dec. 2 IBT Laboratories, a...arch laboratory specializing in immunology and all...ests to evaluate the response of patients whose i...immunodeficiency disorder, chemotherapy drugs, or ...o prevent rejection of a transplant. The company l...
(Date:12/1/2008)...O, Dec. 2 New research ...t-slice computed tomography (CT) scanner in an eme...of stroke victims who receive a potentially life-s...t North Shore Medical Center (NSMC)-Salem Hospital...nnual meeting of the Radiological Society of North...
(Date:12/1/2008)...ORE, Dec. 1 S*BIO Pte Ltd today an...al of SB1518, a potent and orally-active JAK2 inhi... patients with chronic idiopathic myelofibrosis (C...e the safety and tolerability of SB1518 in patient...ents. The Phase 1 part of the study will assess t...
(Date:12/1/2008)...Abstinence is still the best policy , , RO...A new study from Mayo Clinic finds the use of the ...coholic hepatitis, an acute inflammation of the li...e results of the study are published in the Decemb...journal.org/ ). , , VIDEO ALERT: Additiona...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3China Pharma Holdings Inc to Host Second Quarter 2008 Earnings Conference Call at 10 a m EDT Wednesday August 6 2008 6877 1China Pharma Holdings Inc to Host Second Quarter 2008 Earnings Conference Call at 10 a m EDT Wednesday August 6 2008 6877 2Strategies to control TB outdated inadequate 24851 1Strategies to control TB outdated inadequate 24851 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 1Immune system protein accurate predictor of survival in pediatric septic shock 4305 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 3HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 1HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 2HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 3
...Sciences, Inc.,(Nasdaq:GILD) today announced detai...ing aztreonam lysine for inhalation, an,antibiotic...ulmonary Pseudomonas aeruginosa (P. aeruginosa). I...m lysine significantly improved,the time to need f...placebo. All patients received an initial 28 days ...
...x Pharmaceuticals,Inc. (OTCBB:CGXP), a biopharmac...dermatology, today announced the publication,of a ...al,compounds: CSA-8 and CSA-13. The paper appeared...l Agents and Chemotherapy, a,peer-reviewed officia... dedicated to advances in the field of applied,mic...
Other Medicine Technology:Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4
VERSASTEP™ Reposable Short Single-Use For use with VERSASTEP™ Short Reusable Cannula, Dilator.
VersaStep™ Reposable Sterilization Trays.
VERSASTEP™ Plus Long Instrument for applications in laparoscopic procedures., ,The VERSASTEP™ Plus Long Instrument with 150mm Working Length is a unique endoscopic entry device that has
...ade; Blunt Tip Trocar consists of a blunt obturato... , ,The valve body assembly contains an internal ... instruments are inserted or withdrawn. The Autosu...verters to allow insertion of instruments of diffe...
Medicine Products: